This is the question posed by researchers, who also wanted to find out whether swapping out sugar for artificial and natural sweeteners reduces blood sugar levels.
The popular sweetener is ‘possibly carcinogenic’ according to the World Health Organization, who has also reaffirmed it is safe to consume within current permitted use levels.
Industry experts and trade groups are decrying the World Health Organization’s International Agency for Research on Cancer’s pending addition of aspartame to a list of possible carcinogens for humans as unscientific and politically motivated.
A new study – published a month after the World Health Organization (WHO) sounded a cautionary note about the long-term effects of zero-calorie sweeteners such as sucralose and saccharin – suggests some diet sweeteners are not inert and can alter the...
The list of food additives authorised for use in the UK will not change at the end of the Brexit transition period, according to the country's food safety regulator, while the EFSA insists that aspartame does not pose a safety concern at current...
EFSA’s decision-making process may have been biased by ‘conflicts of interest’ and the distribution and sale of aspartame in the EU should be suspended, says the author of a new research dossier calling the safety of the sweetener into question.
Experts have rubbished claims that the methanol content in aspartame threatens consumer health, following the publication of a European Food Safety Authority (EFSA) risk assessment.
BEVERAGEDAILY.COM SPECIAL EDITION: SWEETENER INNOVATION
Ajinomoto’s industrial aspartame business lost billions of yen in 2012, but the company’s Senior VP for North America tells BeverageDaily.com it is working hard to ‘stabilize profitability’.
Food and beverage makers internationally are keeping a careful watch on a natural sweetener from the Chinese monk fruit, although its uptake in the market is still several steps away, indicate analysts.
The European Food Safety Authority (EFSA) said there is no indication that aspartame causes cancer following its assessment of a study that linked regular intake of the sweetener with increased risk of certain cancers.
Higher production costs are taking their toll on aspartame, as Ajinomoto Food Ingredients announces a 15 per cent price hike for non-contractual customers.
SinoSweet is stepping up its activities in the UK this month with the opening of a new sales office for aspartame, which it believes will help sales of the sweetener in the face of rival sucralose.
The number of new food and beverage products containing aspartame has continued to fall since 2005, indicates data from Mintel, while the number of those using sucralose has risen.
Ajinomoto Sweeteners Europe has launched a defamation law suit
against US supermarket Asda over labelling on own-brand products
that calls aspartame a 'nasty'.
Excessive intake of aspartame may inhibit the ability of enzymes in
the brain to function normally, suggests a new review that could
fan the flames of controversy over the sweetener.
Ingredient firm Nutrinova has settled another patent infringement
case related to its acesulfame K product, solidifying its position
in the US sweetener market.
Ingredient firm Nutrinova and distributor Viachem have settled a
patent infringement case related to the "unauthorized"
import of sweetener acesulfame K into the United States.
A new review of research on the safety of aspartame has concluded
that suggestions of adverse effects have 'no credible scientific
basis' - findings that add weight to the argument of those who
stand by the sweetener's...
The publication of a new animal study on aspartame last month has -
as expected -sparked yet another bout of head butting from the two
opposing sides of the debate. But it also highlights a bigger
issue: one of transparency.
Concerns over the safety of aspartame could be reignited after a
new study with rats linked regular intake of the sweetener with
increased risk of leukaemia, lymphomas and breast cancer.
The US Food and Drug Administration (FDA) has reaffirmed its
position on the safety of aspartame, following a review of a
European study that had linked the artificial sweetener to cancer.
An Indian pharmaceutical firm has completed a new sucralose
facility and is ready to begin production of the popular sweetener,
using what it claims to be a non patent-infringing process.
An Indian pharmaceutical firm has completed a new sucralose
facility and is ready to begin production of the popular sweetener,
using what it claims to be a non patent-infringing process.
A new sweetener supplier in the US claims to allow food and
beverage firms to access ingredient supplies from low-cost
manufacturing countries while maintaining Western standards of
quality and service.
The EU's food safety agency today said aspartame is safe for
consumption, contradicting a scientific study by the Ramazzini
Foundation that claimed the artificial sweetener caused cancer.
Food processors are waiting with bated breath for the release next
week of an EU regulatory review either confirming or rejecting the
results of a scientific study claiming that aspartame poses a
cancer risk.
Reports from a fresh Italian study alleging aspartame could pose a
cancer risk are not in harmony with the extensive research that
exist on aspartame, say suppliers of this popular sweetener.
Food makers opt for the latest darling of the sweetener industry,
sucralose, for their new products with fresh data showing this
sweetener gained ground over aspartame and Acesulfame K in new
launches using sweeteners, for the...
Pressure on price and market share for Nutrinova, a leading
supplier of non-nutritive sweetener acesulfame-K, is set to rise as
a key patent for the sweetener will soon reach its deadline,
reports Lindsey Partos.
An editorial in the British Medical Journal this month that
concludes criticisms of aspartame are 'unfounded' adds fuel to the
ongoing debate surrounding this popular sweetener used widely in
food and beverage applications.
Coca-Cola has recalled three of its newest drinks because they
lacked the proper labelling regarding an ingredient, potentially
dangerous to PKU patients.
